People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Starton Therapeutics Inc. | — | Biotechnology | Seed | $10.7M | $8.8M | 2021 |
Roy Waldron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roy Waldron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| NITIN KAUSHAL | 1 | 8 |
| Kenneth Anderson | 1 | 5 |
| Eric Baum | 1 | 4 |
| Fotios Plakogiannis | 1 | 2 |
| Pedro Lichtinger | 1 | 2 |
| Scott Kahn | 1 | 2 |
| Cidnee Vaykovich | 1 | 1 |
| Keith Darragh | 1 | 1 |
| Pedro Waisman | 1 | 1 |
| ROY WALDON | 1 | 1 |
| ROMAN ROGOL | 1 | 1 |
| Nintin Kaushal | 1 | 1 |
| Mohamad Hussein | 1 | 1 |
| Asher Chanan-Khan | 1 | 1 |
| Pedro Lichtinger Waisman | 1 | 1 |
| Moses Dodo | 1 | 1 |
| Jamie Oliver | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.